<p><em>Excluded countries should be ready to issue compulsory licences to access needed drugs</em></p> <p>GENEVA, 11 July 2011 &ndash; An agreement announced today by pharmaceutical company Gilead to licence several HIV/AIDS drugs to the Medicines Patent Pool could improve access to medicines for patients, but excludes several countries with large numbers of people living with HIV, the international medical humanitarian organisation M&eacute;decins Sans Fronti&egrave;res (MSF) said today.</p>